ChiCTR2600120209 版本V1.0 版本创建时间2026/03/10 18:00:11 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600120209 

最近更新日期:

Date of Last Refreshed on:

2026-03-10 18:00:03 

注册时间:

Date of Registration:

2026-03-10 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于围产期指标构建早产儿发生新生儿败血症风险预测模型

Public title:

Development and validation of a risk prediction model for sepsis in preterm infants based on perinatal indicators

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于围产期指标构建早产儿发生新生儿败血症风险预测模型

Scientific title:

Development and validation of a risk prediction model for sepsis in preterm infants based on perinatal indicators

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

唐玲玲 

研究负责人:

唐玲玲 

Applicant:

Lingling Tang 

Study leader:

Lingling Tang 

申请注册联系人电话:

Applicant telephone:

+86 13631470262

研究负责人电话:

Study leader's
telephone:

+86 20 3915 1710

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

370018529@qq.com

研究负责人电子邮件:

Study leader's E-mail:

370018529@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市番禺区南村镇兴南大道521号

研究负责人通讯地址:

广州市番禺区兴南大道521号

Applicant address:

No. 521, Xingnan Avenue, Nancun Town, Panyu District, Guangzhou City, Guangdong Province

Study leader's address:

No. 521, Xingnan Avenue, Panyu District, Guangzhou

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

广东省妇幼保健院(广东省妇产医院、广东省儿童医院)

Applicant's institution:

Guangdong Women and Children Hospital(Guangdong Provincial Hospital of Obstetrics and Gynecology, Guangdong Provincial Children's Hospital)

研究负责人所在单位:

广东省妇幼保健院(广东省妇产医院、广东省儿童医院)

Affiliation of the Leader:

Guangdong Province Hospital for Women and Children Healthcare(Guangdong Provincial Hospital of Obstetrics and Gynecology, Guangdong Provincial Children's Hospital)

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

广东省妇幼保健院医伦第[20251088]号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

广东省妇幼保健院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Guangdong Province Hospital for Women and Children Healthcare

伦理委员会批准日期:

Date of approved by ethic committee:

2025-07-21 00:00:00

伦理委员会联系人:

陈园

Contact Name of the ethic committee:

Chen Yuan

伦理委员会联系地址:

广州市番禺区兴南大道521号

Contact Address of the ethic committee:

No. 521, Xingnan Avenue, Panyu District, Guangzhou

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 20 39151602

伦理委员会联系人邮箱:

Contact email of the ethic committee:

cheny6038@163.com

研究实施负责(组长)单位:

广东省妇幼保健院(广东省妇产医院、广东省儿童医院)

Primary sponsor:

Guangdong Province Hospital for Women and Children Healthcare(Guangdong Provincial Hospital of Obstetrics and Gynecology, Guangdong Provincial Children's Hospital)

研究实施负责(组长)单位地址:

广州市番禺区兴南大道521号

Primary sponsor's address:

No. 521, Xingnan Avenue, Panyu District, Guangzhou

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东省

市(区县):

Country:

China

Province:

Guangdong

City:

单位(医院):

广东省妇幼保健院(广东省妇产医院、广东省儿童医院)

具体地址:

广州市番禺区兴南大道521号

Institution
hospital:

Guangdong Province Hospital for Women and Children Healthcare(Guangdong Provincial Hospital of Obstetrics and Gynecology, Guangdong Provincial Children's Hospital)

Address:

No. 521, Xingnan Avenue, Panyu District, Guangzhou

经费或物资来源:

自选课题(自筹)

Source(s) of funding:

None

研究疾病:

新生儿败血症  

Target disease:

Neonatal sepsis

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

新生儿败血症是早产儿死亡的主要原因之一,但由于其临床表现的非特异性及现有诊断方法的局限性,早期预测仍具挑战性。本研究旨在开发并验证一种基于围产期指标的列线图模型,以预测早产儿败血症风险,为临床早期干预提供依据。  

Objectives of Study:

Neonatal sepsis is one of the main causes of death in premature infants, but early prediction is still challenging due to the non-specific clinical manifest and limitations of current diagnostic methods. This study aims to develop and validate a nomogram model based on perinatal indicators to predict the risk of sepsis in premature infants, a basis for early clinical intervention.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.本院分娩的活产早产儿 2.具有完整的围产期记录 3.母亲产前产时诊疗数据完整 4.未接受外院治疗。

Inclusion criteria

1. Live preterm infants delivered at this hospital 2. Complete perinatal records 3. Complete maternal prenatal and perinatal medical data 4. Did not receive treatment at other hospitals.

排除标准:

1.数据不完整(关键变量缺失>20%) 2.合并先天畸形或遗传病;

Exclusion criteria:

1. Incomplete data (key variables missing >20%) 2. Combine congenital malformations or genetic diseases;

研究实施时间:

Study execute time:

From 2025-09-01 00:00:00 To 2027-09-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-03-10 00:00:00 To 2026-03-31 00:00:00

干预措施:

Interventions:

组别:

早产儿败血症组

样本量:

350

Group:

Preterm neonates sepsis group

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

组别:

对照组

样本量:

2939

Group:

control group

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东省 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

广东省妇幼保健院(广东省妇产医院、广东省儿童医院) 

单位级别:

三级甲等 

Institution
hospital:

Guangdong Province Hospital for Women and Children Healthcare(Guangdong Provincial Hospital of Obstetrics and Gynecology, Guangdong Provincial Children's Hospital)

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

ROC 曲线下面积

指标类型:

主要指标

Outcome:

Area Under the ROC Curve

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not Shared

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic collection and management system

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2026-03-10 18:00:03